receptor antagonist (pKB
values are 9.05 and 8.98 respectively) and 5-HT re-uptake inhibitor (pIC50
= 8.48). Potently antagonizes terminal autoreceptor activity in vitro
and increases extracellular 5-HT levels above those evoked by fluoxetine
(Cat. No. 0927) in vivo
. Also acts as an antagonist at 5-HT2A
values are 7.29 and 7.35 respectively).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties.
Pullar et al.
LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT1B/1D receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell et al.
Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
Morecroft et al.